Efficacy and safety of ixekizumab over 4 years of open-label treatment in a phase 2 study in chronic plaque psoriasis
Journal of the American Academy of Dermatology | Apr 16, 2018
Most read this week
Journal of the American Academy of Dermatology | Apr 16, 2018